Jun 19, 2015 7:00am EDT Can-Fite Subsidiary OphthaliX Signs Definitive Agreement to Acquire Improved Vision Systems Ltd.
Jun 15, 2015 7:00am EDT Can-Fite to Exhibit at Bio International Convention in Philadelphia on June 15 - 18, 2015
Jun 10, 2015 7:00am EDT Can-Fite Granted Notice of Allowance for Patent Covering Manufacturing Process of CF101 in the U.S.
May 04, 2015 8:50am EDT Can-Fite subsidiary, OphthaliX, Signs Term Sheet to Acquire Improved Vision Systems Ltd.
Apr 27, 2015 7:00am EDT Can-Fite Reports Positive Results from Further Analysis of Phase II/III Psoriasis Trial
Apr 20, 2015 7:00am EDT Can-Fite Applies for Orphan Drug Designation in Europe for CF102 in the Treatment of Liver Cancer
Mar 30, 2015 9:11am EDT Can-Fite Reports Top-Line Results from Phase II/III Trial for CF101 in Treatment of Psoriasis